Neuland Laboratories shares tank 12%
Shares of Neuland Laboratories traded 12.48 per cent down in trade on Monday .
By ETMarkets.com | Updated:
Agencies
NEW DELHI: Shares of Neuland Laboratories traded 12.48 per cent down in Monday 's trade. Around 4283 shares changed hands on the counter. The stock opened at Rs 278.9 and touched an intraday high and low of Rs 278.9 and Rs 258.95 , respectively, in the session so far.
The stock quoted a 52-week high of Rs 827.3 and a 52-week low of Rs 255.0 .
India Ratings has assigned rating on company's term loan at A-/Stable.
Early Monday, Sensex hit lower circuit limit of 10 per cent as coronavirus scare continued to weigh on the sentiment. The 30-share Sensex plummeted 10 per cent or 2,991.85 points to 26,924. Market capitalisation of BSE-listed firms retreated to Rs 105.91 lakh crore from Rs 116.09 lakh crore.
Financials
Neuland Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 380.60 Crore) operating in Pharmaceuticals sector.
Neuland Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 622.75 Crore to Sales Value (93.38 % of Total Sales), Export Incentives which contributed Rs 20.85 Crore to Sales Value (3.12 % of Total Sales), Sale of services which contributed Rs 15.57 Crore to Sales Value (2.33 % of Total Sales), Scrap which contributed Rs 4.64 Crore to Sales Value (0.69 % of Total Sales) and Other Operating Revenue which contributed Rs 3.02 Crore to Sales Value (0.45 % of Total Sales)for the year ending 31-Mar-2019.
Promoters holding
Promoters held 35.863132 per cent stake in the company as of Dec 2019 . For the quarter ended Dec 2019 , the company reported a net sales of Rs 203.8437 crore and net profit of Rs 11.1104 crore.
Valuation ratio
The stock quoted a 52-week high of Rs 827.3 and a 52-week low of Rs 255.0 .
India Ratings has assigned rating on company's term loan at A-/Stable.
Early Monday, Sensex hit lower circuit limit of 10 per cent as coronavirus scare continued to weigh on the sentiment. The 30-share Sensex plummeted 10 per cent or 2,991.85 points to 26,924. Market capitalisation of BSE-listed firms retreated to Rs 105.91 lakh crore from Rs 116.09 lakh crore.
Financials
Neuland Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 380.60 Crore) operating in Pharmaceuticals sector.
ADVERTISEMENT
For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 203.84 Crore, up 9.47 % from last quarter Sales of Rs 186.22 Crore and up 18.88 % from last year same quarter Sales of Rs 171.47 Crore Company has reported net profit after tax of Rs 11.11 Crore in latest quarter. Neuland Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 622.75 Crore to Sales Value (93.38 % of Total Sales), Export Incentives which contributed Rs 20.85 Crore to Sales Value (3.12 % of Total Sales), Sale of services which contributed Rs 15.57 Crore to Sales Value (2.33 % of Total Sales), Scrap which contributed Rs 4.64 Crore to Sales Value (0.69 % of Total Sales) and Other Operating Revenue which contributed Rs 3.02 Crore to Sales Value (0.45 % of Total Sales)for the year ending 31-Mar-2019.
Promoters holding
Promoters held 35.863132 per cent stake in the company as of Dec 2019 . For the quarter ended Dec 2019 , the company reported a net sales of Rs 203.8437 crore and net profit of Rs 11.1104 crore.
Valuation ratio
ADVERTISEMENT
It quoted a price-to-earnings ratio of 11.81 and price to book value of 0.54 . Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
